Incyte Corporation technical analysis
Technical analysis of Incyte Corporation (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Incyte Corporation
Incyte Corporation is a biopharmaceutical company that discovers, develops, and commercializes therapeutics for oncological and hematological diseases, operating in the United States, Europe, Canada, and Japan. Its product portfolio includes approved treatments for conditions such as myelofibrosis, chronic myeloid leukemia, and certain lymphomas, as well as topical formulations and clinical-stage products for oncology and dermatological and autoimmune diseases.
Description generated automatically from public sources; it may be inaccurate or out of date.
Incyte Corporation: latest session data
Closing values for October 20, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
116.92 $
−0.26%
50 sessions
121.59 $
−4.09%
200 sessions
107.67 $
+8.31%
Session levels
s2
111.78
Support
s1
112.51
Support
pivot
113.45
Pivot
r1
114.18
Resistance
r2
115.12
Resistance
How to read it
In the October 20, 2026 session Incyte Corporation closed higher at 116.61 $, +2.97% versus the previous session.
The price sits mixed against its moving averages: −0.26% against the 21-session average, −4.09% against the 50 and +8.31% against the 200.
The 14-period RSI reads 48.9, in neutral territory.
MACD stands at -2.593 against a signal line at -2.816: the histogram is positive (+0.223).
ADX reads 25.5, indicating a marked directionality.
Levels computed on the latest session place supports at 112.51 and 111.78 $ and resistances at 114.18 and 115.12 $, around a pivot of 113.45.
The average daily range (ATR) is 3.255 $, or 2.79% of price.
Turnover was 1.3M shares, 79% of the 20-session average.
Over the last twelve months the price ranged between 92.18 and 132.58 $, and today stands −12.04% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the INCY analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Incyte Corporation
How is Incyte Corporation analysed technically?
Technical analysis of Incyte Corporation is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Incyte Corporation?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Incyte Corporation?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Incyte Corporation it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.